These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36217755)

  • 21. Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E.
    Valés-Gómez M; Reyburn HT; Erskine RA; López-Botet M; Strominger JL
    EMBO J; 1999 Aug; 18(15):4250-60. PubMed ID: 10428963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Direct binding of purified HLA class I antigens by soluble NKG2/CD94 C-type lectins from natural killer cells.
    Ding Y; Sumitran S; Holgersson J
    Scand J Immunol; 1999 May; 49(5):459-65. PubMed ID: 10320637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. All-Atom Simulations Reveal a Key Interaction Network in the HLA-E/NKG2A/CD94 Immune Complex Fine-Tuned by the Nonameric Peptide.
    Prašnikar E; Perdih A; Borišek J
    J Chem Inf Model; 2021 Jul; 61(7):3593-3603. PubMed ID: 34196180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interactions between NKG2x immunoreceptors and HLA-E ligands display overlapping affinities and thermodynamics.
    Kaiser BK; Barahmand-Pour F; Paulsene W; Medley S; Geraghty DE; Strong RK
    J Immunol; 2005 Mar; 174(5):2878-84. PubMed ID: 15728498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex.
    Pende D; Sivori S; Accame L; Pareti L; Falco M; Geraghty D; Le Bouteiller P; Moretta L; Moretta A
    Eur J Immunol; 1997 Aug; 27(8):1875-80. PubMed ID: 9295021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The repertoire of killer cell Ig-like receptor and CD94:NKG2A receptors in T cells: clones sharing identical alpha beta TCR rearrangement express highly diverse killer cell Ig-like receptor patterns.
    Uhrberg M; Valiante NM; Young NT; Lanier LL; Phillips JH; Parham P
    J Immunol; 2001 Mar; 166(6):3923-32. PubMed ID: 11238637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The nonclassical MHC class I molecule Qa-1 forms unstable peptide complexes.
    Kambayashi T; Kraft-Leavy JR; Dauner JG; Sullivan BA; Laur O; Jensen PE
    J Immunol; 2004 Feb; 172(3):1661-9. PubMed ID: 14734748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Higher-Order Structure Characterization of NKG2A/CD94 Protein Complex and Anti-NKG2A Antibody Binding Epitopes by Mass Spectrometry-Based Protein Footprinting Strategies.
    Huang RY; Wang Y; Jhatakia AD; Deng AX; Bee C; Deshpande S; Rangan VS; Bezman N; Gudmundsson O; Chen G
    J Am Soc Mass Spectrom; 2021 Jul; 32(7):1567-1574. PubMed ID: 33415981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NK cell CD94/NKG2A inhibitory receptors are internalized and recycle independently of inhibitory signaling processes.
    Borrego F; Kabat J; Sanni TB; Coligan JE
    J Immunol; 2002 Dec; 169(11):6102-11. PubMed ID: 12444112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The HLA-A2 restricted T cell epitope HCV core 35-44 stabilizes HLA-E expression and inhibits cytolysis mediated by natural killer cells.
    Nattermann J; Nischalke HD; Hofmeister V; Ahlenstiel G; Zimmermann H; Leifeld L; Weiss EH; Sauerbruch T; Spengler U
    Am J Pathol; 2005 Feb; 166(2):443-53. PubMed ID: 15681828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigen- or alloantigen-activated CD8+ T cells.
    Mingari MC; Ponte M; Bertone S; Schiavetti F; Vitale C; Bellomo R; Moretta A; Moretta L
    Proc Natl Acad Sci U S A; 1998 Feb; 95(3):1172-7. PubMed ID: 9448304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enriched HLA-E and CD94/NKG2A Interaction Limits Antitumor CD8
    Abd Hamid M; Wang RZ; Yao X; Fan P; Li X; Chang XM; Feng Y; Jones S; Maldonado-Perez D; Waugh C; Verrill C; Simmons A; Cerundolo V; McMichael A; Conlon C; Wang X; Peng Y; Dong T
    Cancer Immunol Res; 2019 Aug; 7(8):1293-1306. PubMed ID: 31213473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HLA-E regulates NKG2C+ natural killer cell function through presentation of a restricted peptide repertoire.
    Lauterbach N; Wieten L; Popeijus HE; Voorter CE; Tilanus MG
    Hum Immunol; 2015 Aug; 76(8):578-86. PubMed ID: 26382247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence of functional Cd94 polymorphism in a free-living house mouse population.
    Knutsen LE; Dissen E; Saether PC; Bjørnsen EG; Piálek J; Storset AK; Boysen P
    Immunogenetics; 2019 Apr; 71(4):321-333. PubMed ID: 30535636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells.
    Kamiya T; Seow SV; Wong D; Robinson M; Campana D
    J Clin Invest; 2019 May; 129(5):2094-2106. PubMed ID: 30860984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The heterodimeric assembly of the CD94-NKG2 receptor family and implications for human leukocyte antigen-E recognition.
    Sullivan LC; Clements CS; Beddoe T; Johnson D; Hoare HL; Lin J; Huyton T; Hopkins EJ; Reid HH; Wilce MC; Kabat J; Borrego F; Coligan JE; Rossjohn J; Brooks AG
    Immunity; 2007 Dec; 27(6):900-11. PubMed ID: 18083576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of p58.2 or CD94/NKG2A inhibitory receptors in an NK-like cell line, YTINDY, leads to HLA Class I-mediated inhibition of cytotoxicity in the p58.2- but not the CD94/NKG2A-expressing transfectant.
    Lin Chua H; Brahmi Z
    Cell Immunol; 2002 Sep; 219(1):57-70. PubMed ID: 12473268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural killer cell surveillance of intracellular antigen processing pathways mediated by recognition of HLA-E and Qa-1b by CD94/NKG2 receptors.
    O'Callaghan CA
    Microbes Infect; 2000 Apr; 2(4):371-80. PubMed ID: 10817639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HLA-E protects glioma cells from NKG2D-mediated immune responses in vitro: implications for immune escape in vivo.
    Wischhusen J; Friese MA; Mittelbronn M; Meyermann R; Weller M
    J Neuropathol Exp Neurol; 2005 Jun; 64(6):523-8. PubMed ID: 15977644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calcineurin-dependent negative regulation of CD94/NKG2A expression on naive CD8+ T cells.
    Cho JH; Kim HO; Webster K; Palendira M; Hahm B; Kim KS; King C; Tangye SG; Sprent J
    Blood; 2011 Jul; 118(1):116-28. PubMed ID: 21540458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.